Price
$22.47
Decreased by -1.75%
Dollar volume (20D)
4.89 M
ADR%
6.41
Earnings report date
Mar 12, 2025
Shares float
25.52 K
Shares short
6.91 M [27.07 K%]
Shares outstanding
48.86 M
Market cap
1.12 B
Beta
N/A
Price/earnings
N/A
20D range
21.69 26.09
50D range
21.69 30.03
200D range
10.90 30.03

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations.

The company is headquartered in Boulder, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 7, 24 -0.48
Increased by +6.24%
-0.50
Increased by +4.36%
Aug 13, 24 -0.41
Increased by 0.00%
-0.55
Increased by +25.45%
May 14, 24 -0.54
Increased by +32.50%
-0.57
Increased by +5.26%
Mar 14, 24 -0.47
Decreased by -138.84%
-0.54
Increased by +12.96%
Nov 9, 23 -0.51
Increased by +29.17%
-0.47
Decreased by -8.51%
Aug 10, 23 -0.41
Increased by +76.70%
-0.36
Decreased by -13.89%
May 11, 23 -0.80
Increased by +64.29%
-0.63
Decreased by -26.98%
Feb 10, 23 1.21
Increased by +157.08%
-0.79
Increased by +253.94%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 0.00
Decreased by N/A%
-23.16 M
Decreased by -11.49%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-19.95 M
Decreased by -19.31%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-22.74 M
Decreased by -74.50%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 440.00 K
Increased by +N/A%
-19.37 M
Decreased by -160.18%
Decreased by -4.40 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-20.77 M
Decreased by -96.79%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-16.72 M
Decreased by -88.11%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-13.03 M
Decreased by -50.31%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
32.19 M
Increased by +483.52%
Increased by +N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY